Publications
738
Citations
48,737
Est. group size
~8
Recurring co-author estimate
Active years
59
Publishing since 1968
Typically publishes in teams of ~15 · 10% small-team papers (≤3 authors) · across 132 venues
- irAE-GPT: leveraging large language models to identify immune-related adverse events in electronic health records and clinical trial datasets
EBioMedicine · 2026
- Bone mineral density changes in patients treated with anti-PD-1 immune checkpoint inhibitors.
Journal of Clinical Oncology · 2026
- Machine learning (ML)-based prediction of fatal immune checkpoint inhibitor (ICI)–associated myocarditis (MC) with multi-cohort validation.
Journal of Clinical Oncology · 2026
- Long term survival outcomes of immune checkpoint inhibitors in metastatic melanoma: Later relapse and long-term outcomes beyond 5 years.
Journal of Clinical Oncology · 2026
- The clinical significance of <i>TET2</i> -driven clonal hematopoiesis ( <i>TET2</i> -CH) in ICI-treated melanoma patients.
Journal of Clinical Oncology · 2026
- Nivolumab plus temozolomide (Nivo/Tem) vs. temozolomide monotherapy in refractory melanoma.
Journal of Clinical Oncology · 2026
- Genomic mediators of acquired resistance to immunotherapy in metastatic melanoma
Cancer Cell · 2025
- Immune Checkpoint Inhibitors for Patients With Preexisting Autoimmune Neurologic Disorders
JAMA Network Open · 2025
- Long-Term Toxicities of Immune Checkpoint Inhibitors
Drugs · 2025
- Artificial Intelligence Algorithm Predicts Response to Immune Checkpoint Inhibitors
Clinical Cancer Research · 2025
- Defining a ‘cells to society’ research framework for appendiceal tumours
Nature reviews. Cancer · 2025
- Steroid-refractory immune mediated hepatitis managed with budesonide in patients with metastatic melanoma: proof of concept and literature review
The Oncologist · 2025
- Genomic copy-number variants drive apoptotic evasion underlying acquired resistance to immune checkpoint inhibitors
Immunity · 2025
- Molecular analysis of immune checkpoint inhibitor associated erythema nodosum-like toxicity
Frontiers in Immunology · 2025
- Targeted therapy for rare BRAF-mutated melanoma: Updated multicenter analysis and launch of a publicly accessible online outcome database
European Journal of Cancer · 2025
- Journal of Clinical Oncology×76
- Journal for ImmunoTherapy of Cancer×30
- European Journal of Cancer×24
- Annals of Oncology×22
- The Oncologist×18
- Christopher D. Lao
Medicine · University of Michigan
- Leslie A. Fecher
Medicine · University of Michigan
- Kari Kendra
Medicine · The Ohio State University
- Siming Li
Medicine · University of Michigan
- Jiayi Yu
Medicine · University of Michigan
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile